Biography

Dr. Karin Wang is an Assistant Professor of Bioengineering at Temple University. Her research program leverages principles from tissue engineering, biomaterials science, soft matter physics, and cell biology to engineer reductionist model systems that probe cell and matrix dynamics. The interdisciplinary approaches used in her lab are aimed at enhancing our fundamental understanding of structure-function relationships from the molecular to multicellular level, to understand how physical forces regulate cell-matrix interactions in health and disease.

Dr. Karin Wang received her BS in Applied Math and Statistics and BE/MS in Biomedical Engineering from Stony Brook University in 2010. She received her PhD in Biomedical Engineering from Cornell University in 2015, studying how the materials properties of matrix proteins drive tumor progression and was awarded NSF DGE GK-12 Teaching Fellowships. During her postdoctoral training from 2015-2018 to investigate the underlying physical drivers of collective cellular migration, she was a NIH NCI F32 Postdoctoral Fellow in the Molecular and Integrative Physiological Sciences Program in the T.H. Chan School of Public Health at Harvard University.

Google Scholar: Publications

Research Interests

  • Cell and matrix mechanobiology
    Structure-function relationships
    Collective migration
    Extracellular matrix remodeling
    Tissue engineered model systems

Courses Taught

Number

Name

Level

BIOE 3719

Introduction to Bioengineering

Undergraduate

BIOE 4471

Mechanobiology

Undergraduate

BIOE 4500

Special Topics: Mechanobiology

Undergraduate

BIOE 5471

Mechanobiology

Graduate

BIOE 5500

Special Topics: Mechanobiology

Graduate

BIOE 5600

Bioengineering Graduate Seminar

Graduate

BIOE 5719

Introduction to Bioengineering

Graduate

Selected Publications

Recent

  • Butowska, K., Han, X., Gong, N., El-Mayta, R., Haley, R.M., Xue, L., Zhong, W., Guo, W., Wang, K., & Mitchell, M.J. (2022). Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy. Acta Pharmaceutica Sinica B. Elsevier BV. doi: 10.1016/j.apsb.2022.07.011

  • Xue, L., Gong, N., Shepherd, S.J., Xiong, X., Liao, X., Han, X., Zhao, G., Song, C., Huang, X., Zhang, H., Padilla, M.S., Qin, J., Shi, Y.i., Alameh, M., Pochan, D.J., Wang, K., Long, F., Weissman, D., & Mitchell, M.J. (2022). Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment. J Am Chem Soc, 144(22), pp. 9926-9937. United States. doi: 10.1021/jacs.2c02706

  • Krohn-Grimberghe, M., Mitchell, M.J., Schloss, M.J., Khan, O.F., Courties, G., Guimaraes, P.P.G., Rohde, D., Cremer, S., Kowalski, P.S., Sun, Y., Tan, M., Webster, J., Wang, K., Iwamoto, Y., Schmidt, S.P., Wojtkiewicz, G.R., Nayar, R., Frodermann, V., Hulsmans, M., Chung, A., Hoyer, F.F., Swirski, F.K., Langer, R., Anderson, D.G., & Nahrendorf, M. (2020). Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche. Nat Biomed Eng, 4(11), pp. 1076-1089. England. doi: 10.1038/s41551-020-00623-7

  • Guimaraes, P.P.G., Tan, M., Tammela, T., Wu, K., Chung, A., Oberli, M., Wang, K., Spektor, R., Riley, R.S., Viana, C.T.R., Jacks, T., Langer, R., & Mitchell, M.J. (2018). Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes. J Control Release, 290, pp. 75-87. Netherlands. doi: 10.1016/j.jconrel.2018.09.025

  • Wan, A.M., Inal, S., Williams, T., Wang, K., Leleux, P., Estevez, L., Giannelis, E.P., Fischbach, C., Malliaras, G.G., & Gourdon, D. (2015). 3D Conducting Polymer Platforms for Electrical Control of Protein Conformation and Cellular Functions. J Mater Chem B, 3(25), pp. 5040-5048. England. doi: 10.1039/C5TB00390C

  • Wang, K., Eguiluz, R., Wu, F., Seo, B.R., Benson, V., Brown, C.N., Fischbach, C., & Gourdon, D. (2014). Altered unfolding and stiffening of fibronectin for tumor progression. Proceedings of the IEEE Annual Northeast Bioengineering Conference, NEBEC, 2014-December. doi: 10.1109/NEBEC.2014.6972970